GPC3/Mesothelin-CAR-γδT Cells Against Cancers

Clinical trial NCT06196294 · RECRUITING

Trial details

NCT number: NCT06196294
Sponsor: Second Affiliated Hospital of Guangzhou Medical University
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Pancreas Cancer Lung Cancer Liver Cancer Mesothelioma CAR-T Cell Therapy Solid Tumor, Adult

Start date: 2024-05-10
Primary completion: 2030-11-30
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.